APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Leflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Leflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchLeflunomide Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Leflunomide Tablets Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Leflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leflunomide Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Leflunomide Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Leflunomide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Leflunomide Tablets include Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd. and Teva Pharmaceutical Industries Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Leflunomide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Leflunomide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Leflunomide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leflunomide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Leflunomide Tablets Segment by Company

Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.

Xiamen Lizhuo Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Meiro Pharmaceutical Co., Ltd.

Jiangsu Yabang Epson Pharmaceutical Co., Ltd.

Hebei Wansui Pharmaceutical Co., Ltd.

Fujian Huitian Biopharmaceutical Co., Ltd.

Changzhou Watson Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Sanofi

Lupin Pharmaceuticals, Inc.

Alembic Pharmaceuticals Inc.

Leflunomide Tablets Segment by Type

Generic Drugs

Original Drugs

Leflunomide Tablets Segment by Application

Hospital

Clinic

Other

Leflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Leflunomide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Leflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Leflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Leflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Leflunomide Tablets Industry Trends Table 2. Leflunomide Tablets Industry Drivers Table 3. Leflunomide Tablets Industry Opportunities and Challenges Table 4. Leflunomide Tablets Industry Restraints Table 5. Global Leflunomide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Leflunomide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Leflunomide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Leflunomide Tablets Sales Market Share by Manufacturers Table 9. Global Leflunomide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Leflunomide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Leflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Leflunomide Tablets Manufacturers, Product Type & Application Table 13. Global Leflunomide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Leflunomide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Generic Drugs Table 17. Major Manufacturers of Original Drugs Table 18. Global Leflunomide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Leflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Leflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Leflunomide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Leflunomide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Leflunomide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Leflunomide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Leflunomide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Leflunomide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Leflunomide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Leflunomide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Leflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Leflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Leflunomide Tablets Sales Market Share by Application (2021-2026) Table 35. Global Leflunomide Tablets Sales Market Share by Application (2027-2032) Table 36. Global Leflunomide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Leflunomide Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Leflunomide Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Leflunomide Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Leflunomide Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Leflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Leflunomide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Leflunomide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Leflunomide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Leflunomide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Leflunomide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Leflunomide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Leflunomide Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Leflunomide Tablets Revenue Market Share by Region (2027-2032) Table 63. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information Table 64. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview Table 65. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 67. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Development Table 68. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information Table 69. Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview Table 70. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 72. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Development Table 73. Qilu Pharmaceutical Co., Ltd. Company Information Table 74. Qilu Pharmaceutical Co., Ltd. Business Overview Table 75. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 77. Qilu Pharmaceutical Co., Ltd. Recent Development Table 78. Meiro Pharmaceutical Co., Ltd. Company Information Table 79. Meiro Pharmaceutical Co., Ltd. Business Overview Table 80. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 82. Meiro Pharmaceutical Co., Ltd. Recent Development Table 83. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information Table 84. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview Table 85. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 87. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Development Table 88. Hebei Wansui Pharmaceutical Co., Ltd. Company Information Table 89. Hebei Wansui Pharmaceutical Co., Ltd. Business Overview Table 90. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 92. Hebei Wansui Pharmaceutical Co., Ltd. Recent Development Table 93. Fujian Huitian Biopharmaceutical Co., Ltd. Company Information Table 94. Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview Table 95. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 97. Fujian Huitian Biopharmaceutical Co., Ltd. Recent Development Table 98. Changzhou Watson Pharmaceutical Co., Ltd. Company Information Table 99. Changzhou Watson Pharmaceutical Co., Ltd. Business Overview Table 100. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 102. Changzhou Watson Pharmaceutical Co., Ltd. Recent Development Table 103. Teva Pharmaceutical Industries Ltd. Company Information Table 104. Teva Pharmaceutical Industries Ltd. Business Overview Table 105. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio Table 107. Teva Pharmaceutical Industries Ltd. Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Leflunomide Tablets Product Portfolio Table 112. Sanofi Recent Development Table 113. Lupin Pharmaceuticals, Inc. Company Information Table 114. Lupin Pharmaceuticals, Inc. Business Overview Table 115. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio Table 117. Lupin Pharmaceuticals, Inc. Recent Development Table 118. Alembic Pharmaceuticals Inc. Company Information Table 119. Alembic Pharmaceuticals Inc. Business Overview Table 120. Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio Table 122. Alembic Pharmaceuticals Inc. Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Leflunomide Tablets Distributors List Table 126. Leflunomide Tablets Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Leflunomide Tablets Product Image Figure 2. Global Leflunomide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leflunomide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Leflunomide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Leflunomide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Leflunomide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Generic Drugs Image Figure 9. Original Drugs Image Figure 10. Global Leflunomide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Leflunomide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Leflunomide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Leflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Leflunomide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Leflunomide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Leflunomide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Leflunomide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Leflunomide Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Leflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Leflunomide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Leflunomide Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Leflunomide Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Leflunomide Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Leflunomide Tablets Sales Market Share by Country (2021-2032) Figure 39. China Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Leflunomide Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Leflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Leflunomide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Leflunomide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Leflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Leflunomide Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Leflunomide Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drugs
  • Original Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  • Xiamen Lizhuo Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Meiro Pharmaceutical Co., Ltd.
  • Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  • Hebei Wansui Pharmaceutical Co., Ltd.
  • Fujian Huitian Biopharmaceutical Co., Ltd.
  • Changzhou Watson Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Lupin Pharmaceuticals, Inc.
  • Alembic Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Leflunomide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Leflunomide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Leflunomide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Leflunomide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Leflunomide Tablets Market Dynamics
  1. 2.1 Leflunomide Tablets Industry Trends
  2. 2.2 Leflunomide Tablets Industry Drivers
  3. 2.3 Leflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Leflunomide Tablets Industry Restraints
3 Leflunomide Tablets Market by Manufacturers
  1. 3.1 Global Leflunomide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Leflunomide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Leflunomide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Leflunomide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Leflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Leflunomide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Leflunomide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Leflunomide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Leflunomide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Leflunomide Tablets Tier 1, Tier 2, and Tier 3
4 Leflunomide Tablets Market by Type
  1. 4.1 Leflunomide Tablets Type Introduction
  2. 4.1.1 Generic Drugs
  3. 4.1.2 Original Drugs
  4. 4.2 Global Leflunomide Tablets Sales by Type
  5. 4.2.1 Global Leflunomide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Leflunomide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Leflunomide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Leflunomide Tablets Revenue by Type
  9. 4.3.1 Global Leflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Leflunomide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Leflunomide Tablets Revenue Market Share by Type (2021-2032)
5 Leflunomide Tablets Market by Application
  1. 5.1 Leflunomide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Leflunomide Tablets Sales by Application
  6. 5.2.1 Global Leflunomide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leflunomide Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Leflunomide Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Leflunomide Tablets Revenue by Application
  10. 5.3.1 Global Leflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Leflunomide Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Leflunomide Tablets Revenue Market Share by Application (2021-2032)
6 Global Leflunomide Tablets Sales by Region
  1. 6.1 Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Leflunomide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Leflunomide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Leflunomide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Leflunomide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Leflunomide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Leflunomide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Leflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Leflunomide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Leflunomide Tablets Revenue by Region
  1. 7.1 Global Leflunomide Tablets Revenue by Region
  2. 7.1.1 Global Leflunomide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Leflunomide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Leflunomide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Leflunomide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Leflunomide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Leflunomide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Leflunomide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Leflunomide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Leflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  2. 8.1.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  6. 8.1.5 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Xiamen Lizhuo Pharmaceutical Co., Ltd.
  8. 8.2.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  12. 8.2.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Qilu Pharmaceutical Co., Ltd.
  14. 8.3.1 Qilu Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Meiro Pharmaceutical Co., Ltd.
  20. 8.4.1 Meiro Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Meiro Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  24. 8.4.5 Meiro Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  26. 8.5.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  30. 8.5.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hebei Wansui Pharmaceutical Co., Ltd.
  32. 8.6.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hebei Wansui Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  36. 8.6.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Fujian Huitian Biopharmaceutical Co., Ltd.
  38. 8.7.1 Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  42. 8.7.5 Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Changzhou Watson Pharmaceutical Co., Ltd.
  44. 8.8.1 Changzhou Watson Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Changzhou Watson Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  48. 8.8.5 Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Teva Pharmaceutical Industries Ltd.
  50. 8.9.1 Teva Pharmaceutical Industries Ltd. Company Information
  51. 8.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  52. 8.9.3 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Leflunomide Tablets Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Lupin Pharmaceuticals, Inc.
  62. 8.11.1 Lupin Pharmaceuticals, Inc. Company Information
  63. 8.11.2 Lupin Pharmaceuticals, Inc. Business Overview
  64. 8.11.3 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio
  66. 8.11.5 Lupin Pharmaceuticals, Inc. Recent Developments
  67. 8.12 Alembic Pharmaceuticals Inc.
  68. 8.12.1 Alembic Pharmaceuticals Inc. Company Information
  69. 8.12.2 Alembic Pharmaceuticals Inc. Business Overview
  70. 8.12.3 Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio
  72. 8.12.5 Alembic Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Leflunomide Tablets Value Chain Analysis
  2. 9.1.1 Leflunomide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Leflunomide Tablets Production Mode & Process
  6. 9.2 Leflunomide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Leflunomide Tablets Distributors
  9. 9.2.3 Leflunomide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst